Patents by Inventor Susanne Aileen Funke

Susanne Aileen Funke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11175288
    Abstract: The invention concerns a method for detecting indicators for determining diseases (disease indicators), in which aggregates of misfolded proteins play a role, and a method for selective quantitation and/or characterization of these disease indicators.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: November 16, 2021
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Eva Birkmann, Kateryna Kravchenko, Oliver Bannach, Carsten Korth, Verian Bader, Steffen Huebinger
  • Patent number: 10889618
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 12, 2021
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • Patent number: 10239923
    Abstract: Peptides specifically binding amyloid beta and to methods of treating and diagnosing Alzheimer's dementia using such peptides are provided.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: March 26, 2019
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Stephan Rudolph, Janine Kutzsche, Susanne Aileen Funke
  • Publication number: 20190085030
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: November 27, 2018
    Publication date: March 21, 2019
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • Patent number: 10167318
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: January 1, 2019
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • Patent number: 10030056
    Abstract: An agent for preventing and/or treating HIV and other viral infections. The agent in particular comprises at least one peptide, including an amino acid sequence, which is suitable for preventing fibrils associated with Alzheimer's disease, and/or homologs, fractions and parts thereof, so as to treat and/or prevent HIV and/or other viral infections.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: July 24, 2018
    Assignee: Forschungszentrum Juelich GmbH
    Inventors: Susanne Aileen Funke, Dieter Willbold, Heiner Schaal, Marek Widera
  • Publication number: 20180072786
    Abstract: Peptides specifically binding amyloid beta and to methods of treating and diagnosing Alzheimer's dementia using such peptides are provided.
    Type: Application
    Filed: March 1, 2016
    Publication date: March 15, 2018
    Inventors: Dieter Willbold, Stephan Rudolph, Janine Kutzsche, Susanne Aileen Funke
  • Publication number: 20170313744
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: April 10, 2017
    Publication date: November 2, 2017
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK, Antonia Nicole KLEIN
  • Patent number: 9611296
    Abstract: Peptides that bind to amino-terminal truncated pEA?3-42, the free glutamic acid residue of which lies in position 3 or 11 in the form of cyclized pyroglutamate. Four oligopeptides were identified using mirror image phage display technology.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: April 4, 2017
    Assignee: Forschungszentrum Juelich GmbH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Yeliz Cinar, Dirk Bartnik, Hans-Ulrich Demuth, Martin Kleinschmidt, Hans-Henning Ludwig
  • Patent number: 9580469
    Abstract: The present invention relates to novel tau protein aggregate-binding peptides, homologs, fragments, parts and polymers thereof and to the use thereof.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: February 28, 2017
    Assignee: Forschungszentrum Juelich GmbH
    Inventors: Susanne Aileen Funke, Dieter Willbold
  • Publication number: 20160376335
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Application
    Filed: September 13, 2016
    Publication date: December 29, 2016
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK
  • Patent number: 9464118
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: October 11, 2016
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik
  • Publication number: 20160161481
    Abstract: The invention concerns a method for detecting indicators for determining diseases (disease indicators), in which aggregates of misfolded proteins play a role, and a method for selective quantitation and/or characterization of these disease indicators.
    Type: Application
    Filed: June 25, 2014
    Publication date: June 9, 2016
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Eva BIRKMANN, Kateryna KRAVCHENKO, Oliver BANNACHI, Carsten KORTH, Verian BADER, Steffen HUEBINGER
  • Publication number: 20160122401
    Abstract: An agent for preventing and/or treating HIV and other viral infections. The agent in particular comprises at least one peptide, including an amino acid sequence, which is suitable for preventing fibrils associated with Alzheimer's disease, and/or homologs, fractions and parts thereof, so as to treat and/or prevent HIV and/or other viral infections.
    Type: Application
    Filed: April 17, 2014
    Publication date: May 5, 2016
    Applicant: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Susanne Aileen FUNKE, Dieter WILLBOLD, Heiner SCHAAL, Marek WIDERA
  • Publication number: 20150307552
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: September 13, 2013
    Publication date: October 29, 2015
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK, Antonia Nicole KLEIN
  • Publication number: 20150299259
    Abstract: The present invention relates to novel tau protein aggregate-binding peptides, homologs, fragments, parts and polymers thereof and to the use thereof.
    Type: Application
    Filed: September 10, 2013
    Publication date: October 22, 2015
    Inventors: Susanne Aileen FUNKE, Dieter WILLBOLD
  • Publication number: 20150284432
    Abstract: Peptides that bind to amino-terminal truncated pEA?3-42, the free glutamic acid residue of which lies in position 3 or 11 in the form of cyclized pyroglutamate. Four oligopeptides were identified using mirror image phage display technology.
    Type: Application
    Filed: September 25, 2013
    Publication date: October 8, 2015
    Inventors: Dieter Willbold, Susanne Aileen Funke, Yeliz Cinar, Dirk Bartnik, Hans-Ulrich Demuth, Martin Kleinschmidt, Hans-Henning Ludwig
  • Patent number: 9051364
    Abstract: A composition includes D-peptides or antibodies to at least one of to prevent a disease and to treat the disease, wherein the D-peptides interact with an amyloid peptide and the antibodies bind to both the D-peptide and the amyloid peptide.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: June 9, 2015
    Assignees: FORSCHUNGSZENTRUM JUELICH GMBH, HEINRICH-HEINE-UNIVERSITAET
    Inventors: Dieter Willbold, Carsten Korth, Andreas Mueller-Schiffmann, Susanne Aileen Funke
  • Publication number: 20150119336
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Application
    Filed: April 5, 2013
    Publication date: April 30, 2015
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik
  • Publication number: 20150037826
    Abstract: The invention relates to standards for quantifying pathogenic aggregates or oligomers of endogenous proteins which characterize a protein aggregation disease, amyloid degeneration or protein misfolding diseases and use of these standards for quantifying these pathogenic aggregates or oligomers.
    Type: Application
    Filed: December 21, 2012
    Publication date: February 5, 2015
    Inventors: Dieter Willbold, Susanne Aileen Funke